Skip to content
ABUSArbutus Biopharma Corp

ABUS holders

Who holds Arbutus Biopharma Corp, from the managers’ Form 13F reports for the quarter ended Sep 30, 2026.

Managers
215
Shares held
132.6M
Value held
$629M
Opened
64
Closed
20

Form 13F covers managers with $100 million or more. Positions are as of the quarter end and filed up to 45 days later; the latest quarter fills in as reports land.

ManagerSharesChangeValueOf portfolioFiled
SJS Investment Consulting Inc.167New$7990.1%Oct 26, 2026
Farther Finance Advisors, LLC136New$6500%Oct 8, 2026
Price T Rowe Associates Inc133.8K±0%$6400.1%Nov 16, 2026
Rothschild Investment LLC130New$6210%Nov 10, 2026
Rialto Wealth Management, LLC116±0%$5550.1%Nov 16, 2026
Federation des caisses Desjardins du Quebec100±0%$4780%Nov 16, 2026
Harbour Investments, Inc.50New$2390%Nov 9, 2026
Clearstead Advisors, LLC25±0%$1200%Nov 6, 2026
Assetmark, Inc17New$810%Oct 21, 2026
DekaBank Deutsche Girozentrale12.5KNew$610.1%Oct 27, 2026
Harbor Capital Advisors, Inc.12.8KNew$610.1%Oct 22, 2026
StoneRidge PMG Advisors, LLC10.1K—$480.1%Nov 4, 2026
State of Alaska, Department of Revenue10KNew$470.1%Oct 15, 2026
Avion Wealth1.5K±0%$70.1%Nov 4, 2026
Hantz Financial Services, Inc.171±0%$10%Nov 9, 2026